Table 4 Univariate and multivariate cox regression analyses for prediction of RFS.

From: Impact of pelvic lymph node dissection on survival outcomes in non-muscle invasive bladder cancer: a multicenter retrospective study

Univariate analysis

HR

95% CI

p value

Age (continuously coded)

1.01

0.98–1.03

0.788

Gender

Female versus male

0.74

0.38–1.46

0.388

Clinical T-stage

cT1 versus cTa/cTis

1.37

0.57–3.019

0.469

Tumor grade

High versus low

1.75

0.70–4.36

0.229

Concomitant CIS

Present versus absent

0.81

0.41–1.59

0.541

Lymphovascular invasion

Present versus absent

1.08

0.56–2.05

0.824

Histological subtypes

Present versus absent

1.88

1.13–3.14

0.015*

Pathological T-stage

pT ≤ 1

Reference

  

pT = 2

2.08

1.03–4.21

0.043*

pT ≥ 3

11

6.27–19.31

<0.001***

Pathological N-status

pNx

Reference

  

pN0

0.33

0.17–0.57

<0.001***

pN+

5.21

2.79–9.70

<0.001***

Multivariate analysis

HR

95% CI

p value

Histological subtypes

Absent

Reference

  

Present

1.21

0.71–2.05

0.489

Pathological T-stage

pT ≤ 1

Reference

  

pT = 2

2.08

1.02–4.25

0.044*

pT ≥ 3

9.37

4.85–18.10

<0.001***

Pathological N-status

pNx

Reference

  

pN0

0.25

0.14–0.44

<0.001***

pN+

1.03

0.49–2.16

0.929

  1. RFS = Recurrence-free survival; HR = Hazard ratio. CI = Confidence interval; * p < 0.05; ** p < 0.01; *** p < 0.001.